Nephrocare Health Services Limited (BOM:544647)
India · Delayed Price · Currency is INR 573.95
-1.80 (-0.31%)
At close: Feb 13, 2026
BOM:544647 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue | 9,524 | 7,558 | 5,662 | 4,373 | 3,169 | 2,845 |
Revenue Growth (YoY) | 117.80% | 33.50% | 29.47% | 37.99% | 11.40% | - |
Cost of Revenue | 5,784 | 4,886 | 3,830 | 3,231 | 1,879 | 1,653 |
Gross Profit | 3,740 | 2,673 | 1,832 | 1,142 | 1,290 | 1,192 |
Selling, General & Admin | 143.36 | 143.36 | 70.39 | 44.99 | 126.15 | 88.85 |
Other Operating Expenses | 1,327 | 837.84 | 713.65 | 591.8 | 913.86 | 701.73 |
Operating Expenses | 2,323 | 1,717 | 1,355 | 1,125 | 1,476 | 1,153 |
Operating Income | 1,417 | 956.04 | 476.58 | 17.16 | -186.26 | 38.96 |
Interest Expense | -612.11 | -188.67 | -190 | -145.86 | -96.93 | -73.59 |
Interest & Investment Income | 119.55 | 119.55 | 83.25 | 42.24 | 35.56 | 47.46 |
Currency Exchange Gain (Loss) | -10.1 | -10.1 | -28.2 | 10.59 | - | - |
Other Non Operating Income (Expenses) | 23.8 | -5.74 | -9.37 | -10.04 | -5.44 | - |
EBT Excluding Unusual Items | 938.48 | 871.08 | 332.26 | -85.91 | -253.06 | 12.83 |
Gain (Loss) on Sale of Investments | 7.55 | 7.55 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | -0.65 | - | - | - |
Asset Writedown | -4.26 | -4.26 | - | - | -27.68 | - |
Pretax Income | 941.77 | 874.37 | 331.61 | -85.91 | -280.74 | 12.83 |
Income Tax Expense | 228.4 | 203.41 | -19.72 | 31.98 | -60.99 | 2.81 |
Net Income | 713.37 | 670.96 | 351.33 | -117.89 | -219.75 | 10.02 |
Net Income to Common | 713.37 | 670.96 | 351.33 | -117.89 | -219.75 | 10.02 |
Net Income Growth | - | 90.98% | - | - | - | - |
Shares Outstanding (Basic) | 86 | 81 | 77 | 77 | 8 | 8 |
Shares Outstanding (Diluted) | 90 | 84 | 80 | 77 | 8 | 23 |
Shares Change (YoY) | 17.24% | 4.81% | 3.72% | 829.32% | -64.32% | - |
EPS (Basic) | 8.31 | 8.28 | 4.55 | -1.53 | -26.51 | 1.28 |
EPS (Diluted) | 7.90 | 8.01 | 4.40 | -1.53 | -26.51 | 0.43 |
EPS Growth | - | 82.05% | - | - | - | - |
Free Cash Flow | - | 355.72 | -50.69 | -603 | -310.52 | -179.91 |
Free Cash Flow Per Share | - | 4.25 | -0.63 | -7.83 | -37.45 | -7.74 |
Gross Margin | 39.27% | 35.36% | 32.36% | 26.12% | 40.70% | 41.89% |
Operating Margin | 14.88% | 12.65% | 8.42% | 0.39% | -5.88% | 1.37% |
Profit Margin | 7.49% | 8.88% | 6.21% | -2.70% | -6.93% | 0.35% |
Free Cash Flow Margin | - | 4.71% | -0.90% | -13.79% | -9.80% | -6.32% |
EBITDA | 2,189 | 1,565 | 945.4 | 419.36 | 170.71 | 345.81 |
EBITDA Margin | 22.99% | 20.70% | 16.70% | 9.59% | 5.39% | 12.16% |
D&A For EBITDA | 771.87 | 608.7 | 468.82 | 402.2 | 356.97 | 306.85 |
EBIT | 1,417 | 956.04 | 476.58 | 17.16 | -186.26 | 38.96 |
EBIT Margin | 14.88% | 12.65% | 8.42% | 0.39% | -5.88% | 1.37% |
Effective Tax Rate | 24.25% | 23.26% | - | - | - | 21.92% |
Revenue as Reported | 9,695 | 7,699 | 5,747 | 4,433 | 3,205 | 2,892 |
Advertising Expenses | - | 52.97 | 18.75 | 12.78 | 88.5 | 57.53 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.